Which laboratory test will be most beneficial in monitoring the effectiveness of drug therapy for hyperthyroidism?

Which laboratory test will be most beneficial in monitoring the effectiveness of drug therapy for hyperthyroidism?

• A. Free thyroxine (FT4)
• B. Free triiodothyronine (FT3)
• C. Triiodothyronine (T3), total
• D. Thyroxine (T4), total

Answer: (D)

The main idea is to track the overall thyroid hormone burden as therapy for hyperthyroidism takes effect. When antithyroid drug therapy works, the body's total production of thyroxine decreases, so the amount of circulating thyroxine should fall toward normal. Measuring total T4 captures this overall hormone load because it reflects both the hormone that’s free and the portion bound to transport proteins. In many patients, total T4 provides a straightforward sense of change in hormone exposure over time, making it a practical choice for monitoring response. Free measurements (like free T4) can be influenced by binding proteins and lab variability, and may not always align with the patient’s actual tissue hormone exposure, while free T3 can be affected by peripheral conversion and might not consistently mirror overall thyroxine burden. Total T3 is less commonly used for monitoring thyroid therapy and can lag or vary independently from clinical status. So, total T4 is considered the most informative option among the choices for gauging how well the drug therapy is controlling hyperthyroidism.

The main idea is to track the overall thyroid hormone burden as therapy for hyperthyroidism takes effect. When antithyroid drug therapy works, the body's total production of thyroxine decreases, so the amount of circulating thyroxine should fall toward normal. Measuring total T4 captures this overall hormone load because it reflects both the hormone that’s free and the portion bound to transport proteins. In many patients, total T4 provides a straightforward sense of change in hormone exposure over time, making it a practical choice for monitoring response.

Free measurements (like free T4) can be influenced by binding proteins and lab variability, and may not always align with the patient’s actual tissue hormone exposure, while free T3 can be affected by peripheral conversion and might not consistently mirror overall thyroxine burden. Total T3 is less commonly used for monitoring thyroid therapy and can lag or vary independently from clinical status.

So, total T4 is considered the most informative option among the choices for gauging how well the drug therapy is controlling hyperthyroidism.